NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2026
Voltar para busca
Dado oficial do USPTO
VECTURA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VECTURA
ST13
US500000098217245Classe
5, 10, 40, 42
Pedido
98217245
Registro
8248997
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 40, 42
Data de depósito
10/10/2023
Data de registro
12/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/05/2026
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Wiltshire, GB
Examinador
PERRY, KIMBERLY B
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Vectura Limited
Representantes
Molly B. Markley YOUNG, BASILE, HANLON & MACFARLANE P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparationspowders for asthma inhalers; pharmaceutical preparationspowders for transdermal injection for the alleviation or prevention of painfor the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparationspulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticalsdrug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field
Classe 10
Surgicalmedicalveterinary apparatusinstruments and parts and fittings therefordrug delivery devices and parts and fittings therefordrug delivery systems being nebulizers for medical purposes; inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapyrespiration therapyparts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field
Classe 40
Custom manufacture of pharmaceuticals; Consulting services in the field of pharmaceutical formulationdevelopment of medical applications for drugs and pharmaceutical formulationsdrug designdrug formulationpharmaceutical formulationdevelopment of pharmaceutical formulations
Classe 42
Scientific research and technological servicesresearchdesignanalysistestingin the field of pharmaceuticals and drug delivery systemsdrug delivery systems and devices; Scientific research and technological servicesresearch in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services;
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/03/2026
PUBO
PUBLISHED FOR OPPOSITION
24/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
27/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/02/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/02/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/01/2026
GNRT
NON-FINAL ACTION E-MAILED
22/01/2026
CNRT
NON-FINAL ACTION WRITTEN
22/01/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
22/01/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
16/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2026
ATRV
ATTORNEY REVIEW COMPLETED
08/01/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
21/04/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/06/2024
GNRT
NON-FINAL ACTION E-MAILED
10/06/2024
CNRT
NON-FINAL ACTION WRITTEN
10/06/2024
DOCK
ASSIGNED TO EXAMINER
29/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/10/2023
NWAP
NEW APPLICATION ENTERED
13/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VECTURA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.